These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 20231205
21. [Genomic approaches to bone and joint diseases. Mutations of RANK, OPG and RANKL genes found in humans]. Kobayashi Y, Takahashi N. Clin Calcium; 2008 Feb; 18(2):202-9. PubMed ID: 18245890 [Abstract] [Full Text] [Related]
22. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mochizuki S, Ikeda T, Mukai M, Okada Y. J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604 [Abstract] [Full Text] [Related]
23. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732 [Abstract] [Full Text] [Related]
24. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Bonfá AC, Seguro LP, Caparbo V, Bonfá E, Pereira RM. Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157 [Abstract] [Full Text] [Related]
26. Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients. Singh MM, Kumar R, Tewari S, Agarwal S. Ann Hum Genet; 2017 May; 81(3):117-124. PubMed ID: 28244588 [Abstract] [Full Text] [Related]
27. [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients]. Wang J, Gao H, Wang K, Li W, Shi Z, Zhang M. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jul; 23(7):777-80. PubMed ID: 19662974 [Abstract] [Full Text] [Related]
30. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. Knevel R, de Rooy DP, Saxne T, Lindqvist E, Leijsma MK, Daha NA, Koeleman BP, Tsonaka R, Houwing-Duistermaat JJ, Schonkeren JJ, Toes RE, Huizinga TW, Brouwer E, Wilson AG, van der Helm-van Mil AH. Arthritis Res Ther; 2014 May 07; 16(3):R108. PubMed ID: 24886600 [Abstract] [Full Text] [Related]
34. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL. J Rheumatol; 2003 Jul 07; 30(7):1406-9. PubMed ID: 12858434 [Abstract] [Full Text] [Related]
35. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC. Arthritis Rheum; 2006 Jan 07; 54(1):90-6. PubMed ID: 16385500 [Abstract] [Full Text] [Related]
36. Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis. Abdi S, Binbaz RA, Mohammed AK, Ansari MGA, Wani K, Amer OE, Alnaami AM, Aljohani N, Al-Daghri NM. Genes (Basel); 2021 Jan 29; 12(2):. PubMed ID: 33572979 [Abstract] [Full Text] [Related]
37. Association of OPG gene polymorphism with susceptibility to rheumatoid arthrits in Chinese Han. Cai YM, Wang J, Wang QW, Long X, Wang WG, Zhang L, Zeng HP, Wu ZC. Immunol Lett; 2015 Jun 29; 165(2):102-6. PubMed ID: 25102365 [Abstract] [Full Text] [Related]
38. Relationship Between RANK and RANKL Gene Polymorphisms with Osteoporosis in Rheumatoid Arthritis Patients. Mohamed RH, Mohamed RH, El-Shahawy EE. Genet Test Mol Biomarkers; 2016 May 29; 20(5):249-54. PubMed ID: 26914636 [Abstract] [Full Text] [Related]